E2F3 and breast cancer: Notably, upregulation of mir-140-5p or suppression of E2F3 or Circ-RNF111 could reduce IC50, cell viability, colony numbers, cell invasion, and glycolysis of paclitaxel-resistant breast cancer lines (52).